Cargando…

Development of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians

Angiogenesis is the process by which new blood vessels form from existing vessel networks. In the past three decades, significant progress has been made in our understanding of angiogenesis; progress driven in large part by the increasing realization that blood vessel growth can promote or facilitat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keane, Pearse A., Sadda, Srinivas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246783/ https://www.ncbi.nlm.nih.gov/pubmed/22220269 http://dx.doi.org/10.1155/2012/483034

Ejemplares similares

Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
por: Keane, Pearse A, et al.
Publicado: (2011)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Central retinal vein occlusion: a case report and review of the literature
por: Alasil, Tarek, et al.
Publicado: (2009)

Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
por: Casalino, Giuseppe, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

VEGF and Intraocular Neovascularization: From Discovery to Therapy
por: Ferrara, Napoleone
Publicado: (2016)

Grading of Age-Related Macular Degeneration: Comparison between Color Fundus Photography, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography
por: Mokwa, Nils F., et al.
Publicado: (2013)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

Subretinal Fluid in Eyes with Active Ocular Toxoplasmosis Observed Using Spectral Domain Optical Coherence Tomography
por: Ouyang, Yanling, et al.
Publicado: (2015)

Correction: Subretinal Fluid in Eyes with Active Ocular Toxoplasmosis Observed Using Spectral Domain Optical Coherence Tomography
por: Ouyang, Yanling, et al.
Publicado: (2015)

Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations
por: Kampougeris, George, et al.
Publicado: (2013)

Evaluation of Cystoid Change Phenotypes in Ocular Toxoplasmosis Using Optical Coherence Tomography
por: Ouyang, Yanling, et al.
Publicado: (2014)

A Clinician's Guide to Artificial Intelligence: How to Critically Appraise Machine Learning Studies
por: Faes, Livia, et al.
Publicado: (2020)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Tumor refractoriness to anti-VEGF therapy
por: Ribatti, Domenico
Publicado: (2016)

Anti-VEGF Therapy and the Retina: An Update
por: Tah, Vikas, et al.
Publicado: (2015)

Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations
por: Levin, Ariana M., et al.
Publicado: (2021)

Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF
por: Sharma, Rajesh K., et al.
Publicado: (2010)

Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma
por: Andrés-Guerrero, Vanessa, et al.
Publicado: (2016)

Safety of intraocular anti-VEGF antibody treatment under in vitro HTLV-1 infection
por: Zong, Yuan, et al.
Publicado: (2023)

Anti-VEGF Cancer Therapy in Nephrology Practice
por: Izzedine, Hassan
Publicado: (2014)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
por: Yerramothu, Praveen
Publicado: (2018)

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)

Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections
por: LoBue, Stephen A, et al.
Publicado: (2023)

A clinician's guide to the assessment and interpretation of noninferiority trials for novel therapies
por: Oczkowski, Simon J W
Publicado: (2014)

Hyperalimentation: A Guide for Clinicians
por: Rice, Henry
Publicado: (1986)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
por: Gahn, Greggory M., et al.
Publicado: (2018)

Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology
por: Trujillo, Cleber A, et al.
Publicado: (2007)

Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
por: Bolinger, Mark T., et al.
Publicado: (2016)

Prevalence and implications of the presence of intraocular silicone oil droplets in patients treated with intravitreal injections of anti-VEGF
por: García, Sandra Banderas, et al.
Publicado: (2022)

Use of Anti-VEGF Agents in Glaucoma Surgery
por: Slabaugh, Mark, et al.
Publicado: (2017)

Management of Neovascular Age-Related Macular Degeneration in Clinical Practice: Initiation, Maintenance, and Discontinuation of Therapy
por: Keane, Pearse A., et al.
Publicado: (2011)

A Clinician’s Guide to Topical Retinoids
por: Motamedi, Melika, et al.
Publicado: (2021)

VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
por: Hilmi, Caroline, et al.
Publicado: (2012)

Anti-VEGF Therapy in Breast and Lung Mouse Models of Cancers
por: Marina, Di Domenico, et al.
Publicado: (2011)

Clinician's Guide to Evaluating and Developing eHealth Interventions for Mental Health
por: Ondersma, Steven J., et al.
Publicado: (2020)

Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015)

Medical treatment of pouchitis: a guide for the clinician
por: Rabbenou, Wendy, et al.
Publicado: (2021)

Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases
por: Sharma, Dhyana, et al.
Publicado: (2023)

Weight stigma and bias: A guide for pediatric clinicians
por: Braddock, Amy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oeqcuncscsbjev6l6rvaggs339